Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials

BACKGROUND: Second‐generation drug eluting stents (DES) may reduce costs and improve clinical outcomes compared to first‐generation DES with improved cost‐effectiveness when compared to bare metal stents (BMS). We aimed to conduct an economic evaluation of a cobalt‐chromium everolimus eluting stent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferko, Nicole, Ferrante, Giuseppe, Hasegawa, James T., Schikorr, Tanya, Soleas, Ireena M., Hernandez, John B., Sabaté, Manel, Kaiser, Christoph, Brugaletta, Salvatore, de la Torre Hernandez, Jose Maria, Galatius, Soeren, Cequier, Angel, Eberli, Franz, de Belder, Adam, Serruys, Patrick W., Valgimigli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434913/
https://www.ncbi.nlm.nih.gov/pubmed/27527508
http://dx.doi.org/10.1002/ccd.26700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434913/
https://www.ncbi.nlm.nih.gov/pubmed/27527508
http://dx.doi.org/10.1002/ccd.26700

Ejemplares similares